---
title: "08:21 ET\n\t\t\t\n\t\t\t\n\t\t\t\tRXST Investors Have Opportunity to Lead RxSight, Inc. Securities Fraud Lawsuit with the Schall Law Firm"
description: "The Schall Law Firm is reminding investors of a class action lawsuit against RxSight, Inc. for securities fraud, alleging violations of the Securities Exchange Act. Investors who purchased shares betw"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/255620805.md"
published_at: "2025-09-02T12:23:02.000Z"
---

# 08:21 ET
			
			
				RXST Investors Have Opportunity to Lead RxSight, Inc. Securities Fraud Lawsuit with the Schall Law Firm

> The Schall Law Firm is reminding investors of a class action lawsuit against RxSight, Inc. for securities fraud, alleging violations of the Securities Exchange Act. Investors who purchased shares between November 7, 2024, and July 8, 2025, are encouraged to contact the firm before September 22, 2025. The lawsuit claims RxSight made false statements regarding customer demand and financial guidance, leading to investor losses when the truth emerged. The class has not yet been certified, and interested parties can join to recover losses.

, /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against RxSight, Inc. ("RxSight" or "the Company") (NASDAQ: RXST) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b\-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Investors who purchased the Company's securities between November 7, 2024 and July 8, 2025, inclusive (the "Class Period"), are encouraged to contact the firm before September 22, 2025.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at \[email protected\].

The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

According to the Complaint, the Company made false and misleading statements to the market. RxSight experienced "adoption challenges" causing declining sales and utilization rates. The Company overstated customer demand for its products. The Company was unlikely to achieve its financial guidance for fiscal year 2025. Based on these facts, the Company's public statements were false and materially misleading throughout the class period. When the market learned the truth about RxSight, investors suffered damages

Join the case to recover your losses.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

**CONTACT:**

The Schall Law Firm  
Brian Schall, Esq.,  
www.schallfirm.com  
Office: 310-301-3335  
\[email protected\]

SOURCE The Schall Law Firm

### Related Stocks

- [RXST.US - RxSight](https://longbridge.com/en/quote/RXST.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| RAL 投資者有機會與 Schall 律師事務所合作，參與對 Ralliant Corporation 的欺詐調查 | RAL 投資者有機會參與由 Schall 律師事務所主導的針對 Ralliant Corporation 的欺詐調查。該調查重點關注潛在的證券法違規行為，特別是關於誤導性陳述和未披露信息。繼 2026 年 2 月 4 日報告的 14 億美元 | [Link](https://longbridge.com/en/news/276096800.md) |
| 15:32 ET Ardent Health, Inc. (ARDT) 的股東如果遭受損失，有機會主導證券欺詐訴訟 | Ardent Health, Inc. (ARDT) 的股東如果遭受損失，有機會領導一起證券欺詐集體訴訟。Frank R. Cruz 律師事務所宣佈，投資者可以在 2026 年 3 月 9 日截止日期之前參與。訴訟指控 Ardent 錯誤陳 | [Link](https://longbridge.com/en/news/276164590.md) |
| 樞紐集團（Hub Group, Inc.）的投資者有機會與 Schall 律師事務所一起參與對該公司的欺詐調查 | Schall 律師事務所正在代表 Hub Group, Inc.的投資者調查潛在的證券法違規行為。調查的重點是 Hub 是否發佈了誤導性聲明並未能披露關鍵信息。在向 SEC 報告財務報告問題後，Hub 的股價下跌了 27%。遭受損失的股東被 | [Link](https://longbridge.com/en/news/276096360.md) |
| 怡安集團｜10-K：2025 財年營收 172 億美元不及預期 |  | [Link](https://longbridge.com/en/news/275945420.md) |
| 17:53 ETARDT 投資者有機會主導 Ardent Health, Inc. 的證券欺詐訴訟 | 羅森律師事務所提醒在 2024 年 7 月 18 日至 2025 年 11 月 12 日期間購買了阿登特健康公司（NYSE: ARDT）證券的投資者，注意 2026 年 3 月 9 日的主要原告截止日期，以便參與證券欺詐訴訟。該事務所聲稱阿 | [Link](https://longbridge.com/en/news/276081275.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.
